Skip to content

NGS for Non-unions

What is the Role of Next-generation Sequencing in Non-union of Orthopaedic Cases

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03937310
Enrollment
120
Registered
2019-05-03
Start date
2019-01-03
Completion date
2022-02-03
Last updated
2019-05-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nonunion of Fracture

Brief summary

The purpose of this study is to investigate the role of genetic testing to look for possible infection as a cause for failure of non-healing fractures. The study aims to compare the results of genetic testing known as NGS to standardized clinical laboratory tests for diagnosing infections to see if NGS may be a better diagnostic tool.

Interventions

DIAGNOSTIC_TESTNext-generation sequencing of swabs collected during surgery

Traditional swabs for culturing as well as swabs for NGS testing will be collected

Sponsors

Rothman Institute Orthopaedics
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

Investigational group: Inclusion: 1. Patients undergoing open biopsy / surgical intervention for nonunion following a traumatic (open or closed) long bone fracture (femur shaft, tibia, humerus) which was initially treated operatively.Inclusion Criteria: 2. Nonunions will be defined as a failure to progress towards expected union within an anticipated timeframe, and this judgment will be made by the attending caring for each patient. No specific timeframe or arbitrary cut points will be defined to allow for the considerable variation in fracture healing and different anatomical sites. 3. Presumed Septic and Aseptic nonunions 4. \>18 years old and able to provide informed consent

Exclusion criteria

Exclusion: 1. Pathological fractures at index injury 2. Patients on antibiotic therapy \<2 weeks prior to surgery INCLUSION/

Design outcomes

Primary

MeasureTime frameDescription
Treatment failure6 months post-opNeed for additional re-operation or intervention within follow-up period

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026